Medicare Enrolled

Dr. Alicia Cabrera, MD

Neurology · Altamonte Springs, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
405 W CENTRAL PKWY STE 1000, Altamonte Springs, FL 32714
4077904990
In practice since 2007 (18 years)
NPI: 1770789000 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cabrera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cabrera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cabrera

Dr. Alicia Cabrera is a neurology specialist in Altamonte Springs, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Cabrera performed 12,220 Medicare services across 1,959 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cabrera received a total of $34,896 from 85 pharmaceutical and/or device companies across 1489 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cabrera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 10% volume in FL $34,896 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 98865 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
12,220
Medicare services
Top 10% in FL for neurology
1,959
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~679 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit 8,500 $5 $10
Office visit, established patient (30-39 min) 2,172 $87 $215
Needle measurement of electrical activity in arm or leg muscles, complete study 298 $147 $201
EEG, extended monitoring 179 $328 $930
Nerve conduction, 7-8 studies 162 $132 $373
New patient office visit (45-59 min) 135 $121 $395
Nerve conduction, 11-12 studies 123 $187 $520
Office visit, established patient, complex (40-54 min) 115 $129 $287
Ultrasound study of arm and leg arteries 66 $62 $170
Testing of autonomic nervous system function and heart rate response to deep breathing 66 $66 $177
Testing of autonomic (sympathetic) nervous system function 66 $90 $257
Measurement of brain wave activity (eeg), continuous 63 $203 $519
New patient office visit, complex (60-74 min) 62 $160 $413
Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional 61 $106 $277
Measurement of brain wave activity with video (veeg), 2-12 hours with continuous monitoring 56 $506 $1,297
Office visit, established patient (10-19 min) 53 $40 $114
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face 32 $115 $327
Nerve conduction, 9-10 studies 11 $144 $443
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$34,896
Total received (2018-2024)
Avg $4,985/year across 7 years
Top 10% in FL for neurology
85
Companies
1,489
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,828 (85.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,638 (10.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,430 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,022
2023
$5,795
2022
$5,165
2021
$3,962
2020
$2,375
2019
$8,000
2018
$3,577

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$5,080
Supernus Pharmaceuticals, Inc.
$1,679
Teva Pharmaceuticals USA, Inc.
$1,601
EMD Serono, Inc.
$1,528
ABBVIE INC.
$1,513
Novartis Pharmaceuticals Corporation
$1,371
AbbVie Inc.
$1,359
NOVARTIS PHARMACEUTICALS CORPORATION
$1,198
ACADIA Pharmaceuticals Inc
$1,197
Genentech USA, Inc.
$1,044
GENZYME CORPORATION
$988
JAZZ PHARMACEUTICALS INC.
$970
Alexion Pharmaceuticals, Inc.
$941
E.R. Squibb & Sons, L.L.C.
$825
UCB, Inc.
$748
Celgene Corporation
$734
PFIZER INC.
$723
Amgen Inc.
$663
Lilly USA, LLC
$656
Biohaven Pharmaceuticals, Inc.
$634
Acorda Therapeutics, Inc
$560
Eisai Inc.
$552
Biohaven Pharmaceutical Holding Company Ltd.
$548
Allergan, Inc.
$503
Amneal Pharmaceuticals LLC
$459
Neurocrine Biosciences, Inc.
$360
Lundbeck LLC
$353
Adamas Pharmaceuticals, Inc.
$344
Horizon Therapeutics plc
$338
Allergan Inc.
$333
UPSHER-SMITH LABORATORIES LLC
$331
Avanir Pharmaceuticals, Inc.
$278
Upsher-Smith Laboratories LLC
$255
US WorldMeds, LLC
$250
BANNER LIFE SCIENCES, LLC
$247
TG Therapeutics, Inc.
$236
Corium, LLC
$210
Mallinckrodt Hospital Products Inc.
$192
Janssen Pharmaceuticals, Inc
$186
Takeda Pharmaceuticals U.S.A., Inc.
$175
Sunovion Pharmaceuticals Inc.
$162
EISAI INC.
$158
Abbott Laboratories
$151
Grifols USA, LLC
$144
TG THERAPEUTICS, INC.
$143
Genentech, Inc.
$137
CSL Behring
$135
LivaNova USA, Inc.
$114
SCILEX PHARMACEUTICALS INC.
$95
EMD Serono Research & Development Institute, Inc.
$92
Kyowa Kirin, Inc.
$84
Otsuka America Pharmaceutical, Inc.
$83
ARGENX US, INC.
$81
Mallinckrodt LLC
$79
Currax Pharmaceuticals LLC
$76
GE Healthcare
$70
Mallinckrodt Enterprises LLC
$69
SK Life Science, Inc.
$67
Bayer HealthCare Pharmaceuticals Inc.
$66
ARBOR PHARMACEUTICALS, INC.
$59
Banner Life Sciences, LLC
$50
Zyla Life Sciences
$46
Avion Pharmaceuticals
$45
Janssen Biotech, Inc.
$42
Scilex Pharmaceuticals Inc.
$38
Egalet US Inc
$37
Bausch Health US, LLC
$36
Neurelis, Inc.
$35
CATALYST PHARMACEUTICALS, INC.
$32
Sumitomo Pharma America, Inc.
$29
Boston Scientific Corporation
$27
Zyla Life Sciences, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
Cycle Pharmaceuticals Inc
$26
GE HEALTHCARE
$22
GE HealthCare
$21
GRT US Holding, Inc.
$17
Aprecia Pharmaceuticals, LLC
$17
IMPEL PHARMACEUTICALS INC.
$16
MDD US Operations, LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Promius Pharma LLC
$13
Arbor Pharmaceuticals, Inc.
$13
Piramal Imaging Limited
$13
Dynasplint Systems Inc.
$12
Top 3 companies account for 24.0% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CONTRAVE · COPAXONE · Cambia · DARZALEX · DUOPA · Dhivy · Dynasplint · EMGALITY · EPIDIOLEX · Edarbi · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LUX-Dx Insertable Cardiac Monitor · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · PLEGRIDY · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in FL.

Equivalent to $286 per 100 Medicare services performed
Looking for a neurology specialist in Altamonte Springs?
Compare neurologists in the Altamonte Springs area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
90
Per 100K population
19.0
County median income
$83,030
Nearest hospital
ASPIRE HEALTH PARTNERS
6.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cabrera is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), with low-engagement industry engagement in the top 10% of FL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cabrera experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Cabrera performed 8,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cabrera receive payments from pharmaceutical companies?
Yes. Dr. Cabrera received a total of $34,896 from 85 companies across 1,489 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cabrera's costs compare to other neurologists in Altamonte Springs?
Dr. Cabrera's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cabrera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →